EUVIMEDEUVIMED entdecken
Crossref

Lower proportion of intra-thyroidal B lymphocytes CD20+ associated to methimazole and lack of influence of iodide on lymphocyte subpopulations in Graves' disease

Ana Carolina Barros Silva, Ingrid Iara Damas, Camila Aparecida Moma, Icleia Siqueira Barreto, Denise Engelbrecht Zantut-Wittmann

Molecular and Cellular Endocrinology · 2024

DOI: 10.1016/j.mce.2024.112331 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular and Cellular Endocrinology, 2024. Verfasst von Ana Carolina Barros Silva und 4 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology Division, Department of Internal Medicine, School of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil. Hauptthemen laut MEDLINE: Graves Disease, Methimazole, Thyroid Gland, Antigens, CD20. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: UNICAMP FAEPEX.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Graves' disease (GD), an autoimmune thyroid disease, is one of the main autoimmune diseases in the general population. It is known that the pathophysiology of this disease may be related to immunological mechanisms dysregulation. These mechanisms can be influenced by GD therapies, such as iodide or antithyroid drugs (ATD). OBJECTIVE: Verify relation between clinical, biochemical and treatment modalities used prior to surgery and histopathological characteristics observed in total thyroidectomy products from patients previously diagnosed with Graves' disease. Furthermore, these data were related to composition of lymphocytic infiltrate in terms of proportions of lymphocytes CD4+, CD8+, CD25+ and CD20+. We aim to contribute to the understanding of the evolution pattern of GD, whose pathophysiology is not yet completely understood. METHODS: Cross-sectional study assessing thyroidectomy products for the presence of lymphocytic infiltrate, as well as the proportion and intensity of CD4+, CD8+, CD25+ and CD20+ markers. We selected 50 patients who underwent total or partial thyroidectomy in a tertiary service between 1996 and 2013 due to GD with histopathological confirmation. The control group (non-autoimmune disease group) consisted of 12 patients with histopathological data compatible with normal perilesional thyroid parenchyma. The intensity of lymphocytic infiltrate and immunohistochemical expression of the markers CD4+ (helper T lymphocytes), CD8+ (cytotoxic T lymphocytes), CD25+ (regulatory T lymphocytes) and CD20+ (B lymphocytes) were retrospectively evaluated and relationship with ultrasound, laboratory and clinical data was assessed. RESULTS: No differences were found in intensity, presence of lymphoid follicles, and expression of CD4+/CD8+/CD25+ in patients with GD who did or did not use ATD or iodide. In the group that did not use ATD, a higher proportion of CD20+ expression was found. The GD group was associated with hyperplastic epithelium and the control group was associated with simple epithelium. There was no difference in ultrasound thyroid volume between the groups. In GD patients with mild lymphocytic infiltrate, higher free thyroxin (FT4) levels were observed than those in patients with no infiltrate or moderate infiltrate. CONCLUSION: We found a lower proportion of intrathyroidal CD20+ B lymphocytes in patients under use of methimazole. However, no difference was observed in intrathyroidal lymphocyte subpopulations related to the short-term use of iodide. The understanding of thyroid autoimmunity, as well as identifying points of pharmacological modulation, are very important for advancement and improvement in treatments for these diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graves DiseaseMethimazoleThyroid GlandAntigens, CD20HumansFemaleMaleAdultMiddle AgedIodidesCross-Sectional StudiesB-LymphocytesAntithyroid AgentsLymphocyte SubsetsThyroidectomyAged

Stichwörter der Autor:innen

Graves' diseaseIntrathyroidal lymphocyte subpopulationsIodideMethimazole

Substanzen

MethimazoleAntigens, CD20IodidesAntithyroid Agents

Autor:innen und Institutionen

  • Endocrinology Division, Department of Internal Medicine, School of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil.
  • Department of Pathology, School of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil.
  • Endocrinology Division, Department of Internal Medicine, School of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil. Electronic address: zantutw@unicamp.br.

Förderung

  • UNICAMP FAEPEX

Zitieren

APA

Barros Silva, A. C., Damas, I. I., Moma, C. A., Barreto, I. S., & Zantut-Wittmann, D. E. (2024). Lower proportion of intra-thyroidal B lymphocytes CD20+ associated to methimazole and lack of influence of iodide on lymphocyte subpopulations in Graves' disease. Molecular and Cellular Endocrinology. https://doi.org/10.1016/j.mce.2024.112331

Vancouver

Barros Silva AC, Damas II, Moma CA, Barreto IS, Zantut-Wittmann DE. Lower proportion of intra-thyroidal B lymphocytes CD20+ associated to methimazole and lack of influence of iodide on lymphocyte subpopulations in Graves' disease. Molecular and Cellular Endocrinology. 2024. doi:10.1016/j.mce.2024.112331

BibTeX
@article{BarrosSilva2024,
  author = {Barros Silva, Ana Carolina and Damas, Ingrid Iara and Moma, Camila Aparecida and Barreto, Icleia Siqueira and Zantut-Wittmann, Denise Engelbrecht},
  title = {Lower proportion of intra-thyroidal B lymphocytes CD20+ associated to methimazole and lack of influence of iodide on lymphocyte subpopulations in Graves' disease},
  journal = {Molecular and Cellular Endocrinology},
  year = {2024},
  doi = {10.1016/j.mce.2024.112331}
}
Kostenlos starten →